Real-time enrollment status for this alzheimer disease clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 10:19 PM UTC
| NCT Number | NCT07158905 |
| Recruiting Status | Recruiting |
| Condition | Alzheimer Disease |
| Phase | PHASE1 |
| Target Enrollment | 48 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Institute for Molecular Medicine |
| Last Updated on CT.gov | August 21, 2026 (1 week ago) |
As of August 30, 2026: Clinical trial NCT07158905 is currently recruiting participants. This phase1 study for alzheimer disease is actively seeking new participants at 6 locations across the United States. The study is sponsored by Institute for Molecular Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07158905 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07158905 was last updated 1 week ago (August 21, 2026). HelloStudys verifies this status automatically.